PTCT icon

PTC Therapeutics

99 hedge funds and large institutions have $1.07B invested in PTC Therapeutics in 2014 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
99
Holders Change
+15
Holders Change %
+17.86%
% of All Funds
2.87%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
33
Increased
23
Reduced
26
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
O
101
OrbiMed
New York
-$4.66M -178,100 Closed
PC
102
Pier Capital
Connecticut
-$3.54M -135,445 Closed
Balyasny Asset Management
103
Balyasny Asset Management
Illinois
-$1.09M -41,820 Closed
ARC
104
Absolute Return Capital
Massachusetts
-$839K -32,080 Closed
D.E. Shaw & Co
105
D.E. Shaw & Co
New York
-$635K -24,292 Closed
Renaissance Technologies
106
Renaissance Technologies
New York
-$565K -21,600 Closed
Jane Street
107
Jane Street
New York
-$469K -17,947 Closed
BACM
108
Blue Arrow Capital Management
New York
-$353K -13,500 Closed
Susquehanna International Group
109
Susquehanna International Group
Pennsylvania
-$279K -10,666 Closed
Bank of Montreal
110
Bank of Montreal
Ontario, Canada
-$269K -10,290 Closed
Nuveen Asset Management
111
Nuveen Asset Management
Illinois
-$317K -8,758 Closed
EWM
112
Evercore Wealth Management
New York
-$78K -3,000 Closed
VFA
113
Virtus Fund Advisers
Connecticut
-$50K -1,894 Closed
U
114
UBS
Switzerland
-$42K -1,598 Closed
BJ
115
BlackRock Japan
Japan
-$28K -1,080 Closed
GSC
116
Ground Swell Capital
South Carolina
-$3K -100 Closed
TRCT
117
Tower Research Capital (TRC)
New York
-$1K -37 Closed